|
SQI Diagnostics builds multiplexed assays to enable simultaneous detection of proteins, antibodies and cytokines. SQI's platform is based on Ig_PLEX™ technology, a proprietary combination of patterned microarrays and multiple fluorescent wavelengths enabling simultaneous quantitative measurement of multiple capture proteins / drug molecules, isotype antibodies, and subclass antibodies, all in one well. The platform is tunable, enabling both RUO or IVD levels of sensitivity, dynamic range, and reproducibility. SQI is proud to provide our customers the benefits of an assay development IVD pedigree, world leading capabilities to spot proteins cleanly and reproducibly, patented and exclusive three level in-well multiplexing, and flexible automated workflow with the benefits of complete load & go automation. Our customers are diagnostic reference labs, pharmaceutical drug / vaccine research labs, or assay manufacturers migrating to an automated multiplexed solution. They all value the ability to use SQI's technology to reproducibly generate multiplexed biomarker results at three levels simultaneously in one sample, at the protein level, at the isotype level, and at the subclass level. SQI Diagnostics and Algorithme Pharma to Develop
|
